Trial of the Use of Antenatal Corticosteroids in Developing Countries

NCT01084096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103117

Last updated 2024-12-09

Study results available
· View outcomes & findings →

Summary

Multi-country two-arm, parallel cluster randomized controlled trial to reduce neonatal mortality through increasing the rate of antenatal corticosteroid administration to eligible women.

Conditions

Interventions

BEHAVIORAL

Increasing use of Antenatal Corticosteroids (ACS)

Intervention clusters: * Increasing administration of ACS to pregnant women at high risk of preterm birth (HRPB) by providing health providers with kits containing dexamethasone, syringes, and instructions. Eligible women receive four injections of 6 mg dexamethasone from the kit or regimen of choice at the site. * Improving identification of women at HRPB by diffusing recommendations for ACS use to health care providers, training health care providers to identify signs of preterm labor and eligibility criteria for ACS use, providing reminders to healthcare providers on the use of the kits, and using a color-coded tape to measure uterine height to estimate gestational age in women at HRPB with unknown gestational age. Control clusters: no specific intervention for comparison. Both intervention and control clusters: Birth attendants trained in essential newborn care of LBW infants and instructed to teach mothers how to provide care to premature infants.

Sponsors & Collaborators

  • RTI International

    collaborator OTHER
  • Tulane University School of Medicine

    collaborator OTHER
  • Institute for Clinical Effectiveness and Health Policy

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • University Teaching Hospital, Lusaka, Zambia

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Universidad Francisco Marroquín

    collaborator OTHER
  • Jawaharlal Nehru Medical College

    collaborator OTHER
  • Christiana Care Health Services

    collaborator OTHER
  • Aga Khan University

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • Indiana University

    collaborator OTHER
  • Moi Univeristy

    collaborator OTHER
  • Lata Medical Research Foundation, Nagpur

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Principal Investigators

  • Fernando Althabe, M.D. · Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • Argentina
  • Guatemala
  • India
  • Kenya
  • Pakistan
  • Zambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084096 on ClinicalTrials.gov